Cargando…

Seroprevalence of anti SARS-CoV-2 IgG antibodies among adults in Jammu district, India: A community-based study

BACKGROUND & OBJECTIVES: Serology testing is essential for immunological surveillance in the population. This serosurvey was conducted to ascertain the cumulative population immunity against SARS-CoV-2 among adults in Jammu district and to understand the association of seropositivity with sociod...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Dinesh, Sidhu, Meena, Dogra, Sandeep, Kumar, Bhupinder, Sahni, Bhavna, Yadav, Arvind Kumar, Bala, Kiran, Kumari, Rashmi, Mahajan, Richa, Bavoria, Shalli, Kalotra, Anuradha, Gupta, Sachin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552381/
https://www.ncbi.nlm.nih.gov/pubmed/35859442
http://dx.doi.org/10.4103/ijmr.IJMR_4489_20
_version_ 1784806238171693056
author Kumar, Dinesh
Sidhu, Meena
Dogra, Sandeep
Kumar, Bhupinder
Sahni, Bhavna
Yadav, Arvind Kumar
Bala, Kiran
Kumari, Rashmi
Mahajan, Richa
Bavoria, Shalli
Kalotra, Anuradha
Gupta, Sachin
author_facet Kumar, Dinesh
Sidhu, Meena
Dogra, Sandeep
Kumar, Bhupinder
Sahni, Bhavna
Yadav, Arvind Kumar
Bala, Kiran
Kumari, Rashmi
Mahajan, Richa
Bavoria, Shalli
Kalotra, Anuradha
Gupta, Sachin
author_sort Kumar, Dinesh
collection PubMed
description BACKGROUND & OBJECTIVES: Serology testing is essential for immunological surveillance in the population. This serosurvey was conducted to ascertain the cumulative population immunity against SARS-CoV-2 among adults in Jammu district and to understand the association of seropositivity with sociodemographic and clinical correlates. METHODS: On September 30 and October 1, 2020, a household survey was done in 20 villages/wards chosen from 10 health blocks in district Jammu, India. Demographic, clinical and exposure information was collected from 2000 adults. Serum samples were screened for IgG antibodies using COVID Kavach MERILISA kit. Tests of association were used to identify risk factors associated with IgG positivity. Crude odds ratio with 95 per cent confidence intervals (CIs) was calculated during univariate analysis followed by logistic regression. RESULTS: Overall adjusted seroprevalence for SARS-CoV-2 was 8.8 per cent (95% CI: 8.78-8.82); it varied from 4.1 per cent in Chauki choura to 16.7 per cent Pallanwalla across 10 blocks in the district. Seropositivity was observed to be comparatively higher in 41-50 and 61-70 yr age groups, among males and in rural areas. Fever, sore throat, cough, dyspnoea, myalgias, anosmia, ageusia, fatigue, seizures, history of exposure, medical consultation, hospitalization and missing work showed significant association with seropositivity on univariate analysis. On logistic regression, only sore throat, myalgia and missing work showed significant adjusted odds of IgG positivity. Extrapolation to adult population suggested that exposure to SARS-CoV-2 was 14.4 times higher than reported cases, translating into Infection fatality rate of 0.08 per cent. INTERPRETATION & CONCLUSIONS: Since a major part of population was immunologically naive, all efforts to contain COVID-19 need to be vigorously followed while these baseline results provide an important yardstick to monitor the trends of COVID-19 and guide locally appropriate control strategies in the region.
format Online
Article
Text
id pubmed-9552381
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-95523812022-10-12 Seroprevalence of anti SARS-CoV-2 IgG antibodies among adults in Jammu district, India: A community-based study Kumar, Dinesh Sidhu, Meena Dogra, Sandeep Kumar, Bhupinder Sahni, Bhavna Yadav, Arvind Kumar Bala, Kiran Kumari, Rashmi Mahajan, Richa Bavoria, Shalli Kalotra, Anuradha Gupta, Sachin Indian J Med Res Original Article BACKGROUND & OBJECTIVES: Serology testing is essential for immunological surveillance in the population. This serosurvey was conducted to ascertain the cumulative population immunity against SARS-CoV-2 among adults in Jammu district and to understand the association of seropositivity with sociodemographic and clinical correlates. METHODS: On September 30 and October 1, 2020, a household survey was done in 20 villages/wards chosen from 10 health blocks in district Jammu, India. Demographic, clinical and exposure information was collected from 2000 adults. Serum samples were screened for IgG antibodies using COVID Kavach MERILISA kit. Tests of association were used to identify risk factors associated with IgG positivity. Crude odds ratio with 95 per cent confidence intervals (CIs) was calculated during univariate analysis followed by logistic regression. RESULTS: Overall adjusted seroprevalence for SARS-CoV-2 was 8.8 per cent (95% CI: 8.78-8.82); it varied from 4.1 per cent in Chauki choura to 16.7 per cent Pallanwalla across 10 blocks in the district. Seropositivity was observed to be comparatively higher in 41-50 and 61-70 yr age groups, among males and in rural areas. Fever, sore throat, cough, dyspnoea, myalgias, anosmia, ageusia, fatigue, seizures, history of exposure, medical consultation, hospitalization and missing work showed significant association with seropositivity on univariate analysis. On logistic regression, only sore throat, myalgia and missing work showed significant adjusted odds of IgG positivity. Extrapolation to adult population suggested that exposure to SARS-CoV-2 was 14.4 times higher than reported cases, translating into Infection fatality rate of 0.08 per cent. INTERPRETATION & CONCLUSIONS: Since a major part of population was immunologically naive, all efforts to contain COVID-19 need to be vigorously followed while these baseline results provide an important yardstick to monitor the trends of COVID-19 and guide locally appropriate control strategies in the region. Wolters Kluwer - Medknow 2022-01 /pmc/articles/PMC9552381/ /pubmed/35859442 http://dx.doi.org/10.4103/ijmr.IJMR_4489_20 Text en Copyright: © 2022 Indian Journal of Medical Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Kumar, Dinesh
Sidhu, Meena
Dogra, Sandeep
Kumar, Bhupinder
Sahni, Bhavna
Yadav, Arvind Kumar
Bala, Kiran
Kumari, Rashmi
Mahajan, Richa
Bavoria, Shalli
Kalotra, Anuradha
Gupta, Sachin
Seroprevalence of anti SARS-CoV-2 IgG antibodies among adults in Jammu district, India: A community-based study
title Seroprevalence of anti SARS-CoV-2 IgG antibodies among adults in Jammu district, India: A community-based study
title_full Seroprevalence of anti SARS-CoV-2 IgG antibodies among adults in Jammu district, India: A community-based study
title_fullStr Seroprevalence of anti SARS-CoV-2 IgG antibodies among adults in Jammu district, India: A community-based study
title_full_unstemmed Seroprevalence of anti SARS-CoV-2 IgG antibodies among adults in Jammu district, India: A community-based study
title_short Seroprevalence of anti SARS-CoV-2 IgG antibodies among adults in Jammu district, India: A community-based study
title_sort seroprevalence of anti sars-cov-2 igg antibodies among adults in jammu district, india: a community-based study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552381/
https://www.ncbi.nlm.nih.gov/pubmed/35859442
http://dx.doi.org/10.4103/ijmr.IJMR_4489_20
work_keys_str_mv AT kumardinesh seroprevalenceofantisarscov2iggantibodiesamongadultsinjammudistrictindiaacommunitybasedstudy
AT sidhumeena seroprevalenceofantisarscov2iggantibodiesamongadultsinjammudistrictindiaacommunitybasedstudy
AT dograsandeep seroprevalenceofantisarscov2iggantibodiesamongadultsinjammudistrictindiaacommunitybasedstudy
AT kumarbhupinder seroprevalenceofantisarscov2iggantibodiesamongadultsinjammudistrictindiaacommunitybasedstudy
AT sahnibhavna seroprevalenceofantisarscov2iggantibodiesamongadultsinjammudistrictindiaacommunitybasedstudy
AT yadavarvindkumar seroprevalenceofantisarscov2iggantibodiesamongadultsinjammudistrictindiaacommunitybasedstudy
AT balakiran seroprevalenceofantisarscov2iggantibodiesamongadultsinjammudistrictindiaacommunitybasedstudy
AT kumarirashmi seroprevalenceofantisarscov2iggantibodiesamongadultsinjammudistrictindiaacommunitybasedstudy
AT mahajanricha seroprevalenceofantisarscov2iggantibodiesamongadultsinjammudistrictindiaacommunitybasedstudy
AT bavoriashalli seroprevalenceofantisarscov2iggantibodiesamongadultsinjammudistrictindiaacommunitybasedstudy
AT kalotraanuradha seroprevalenceofantisarscov2iggantibodiesamongadultsinjammudistrictindiaacommunitybasedstudy
AT guptasachin seroprevalenceofantisarscov2iggantibodiesamongadultsinjammudistrictindiaacommunitybasedstudy